Authors


Scott Knoer, PharmD

Latest:

How Pharmacist Provider Status Is Crucial in Fighting the Opioid Epidemic

Progressive Ohio law adds pharmacists as a key patient care team member.


Antonio Ciaccia

Latest:

How Pharmacist Provider Status Is Crucial in Fighting the Opioid Epidemic

Progressive Ohio law adds pharmacists as a key patient care team member.


John Bou

Latest:

Opinion: Big Storm Brewing for American Specialty Pharmacies and Patients

Specialty pharmacy prescriptions are plagued by a myraid of complications.


Craig Ford

Latest:

The Role of Data Mitigating Drug Diversion

As the U.S. opioid addiction crisis continues to worsen, the pharmacy industry’s role in addressing the epidemic continues to increase.


Rick Grape

Latest:

The Role of Data Mitigating Drug Diversion

As the U.S. opioid addiction crisis continues to worsen, the pharmacy industry’s role in addressing the epidemic continues to increase.


John W. Holaday, PhD

Latest:

How Pharmacists Can Encourage the Disposal of Unused Prescriptions

By heading off the misuse of unused medications, pharmacists can play a key role in combatting opioid diversion, accidental poisonings and environmental pollution.


Daniel R. Verdon

Latest:

CDC Calls on Pharmacists to Aid HIV Epidemic

Pharmacists need to remain vigilant about HIV with testing, prevention, treatment, and education of HIV.


Peter Vlasses, PharmD

Latest:

Opinion: PharmD Quality vs Quantity

"Our focus is making sure students have the best information to make career and program decisions at the time of application," writes Peter Vlasses.


Philip Grauss, PharmD

Latest:

Opinion: The Future of Pharmacy

An open letter to the California State Board of Pharmacy.


Lester Nathan, MS

Latest:

Opinion: Your Approach to Hiring is All Wrong

"Neither your gut nor peer advice will get you the caliber people you need", writes Nathan


Brittany Hoffmann-Eubanks, PharmD, MBA

Latest:

Implementing Enhanced Community Pharmacy Services

New study examines effective implementation of team-based care in community pharmacies. 


Capt. Mary E. Kremzner, PharmD, MPH, BCGP,

Latest:

Pharmacists at the FDA: Drug Information Specialists

Agents of regulatory guidance, drug problem reports, and whistleblowers.


Sonia Kim, PharmD, MS

Latest:

Pharmacists at the FDA: Drug Information Specialists

Agents of regulatory guidance, drug problem reports, and whistleblowers.


Terry McInnis, MD, MPH

Latest:

New Institute Aims to Get the Medications Right

Comprehensive medication management may lower costs and improve lives. 


Gary Frisch, RPh

Latest:

Discount Cards: A Rebuttal

"The real problem to be solved is “Why do patients struggle to buy their prescriptions?” writes Frisch. 


Paul W. Abramowitz, PharmD

Latest:

Opinion: Clinician Burnout is Everyone's Problem

How can we protect the health of the millions of people who protect our own?


Jonathan Ni

Latest:

Physician Dispensing and the Opioid Crisis

Pharmacists must continue to minimize the convenience gap between physician and pharmacy.


Nicholas Benedict, MBA

Latest:

Physician Dispensing and the Opioid Crisis

Pharmacists must continue to minimize the convenience gap between physician and pharmacy.


Sally Rafie, PharmD, BCPS, NCMP

Latest:

Birth Control Services Help Attract and Keep Patients

Prescribing more hormonal methods is an important expansion of existing services and offerings.


Wiktoria Bogdanska, PharmD

Latest:

New Drug Review: Vraylar for Bipolar I Disorder

Cariprazine demonstrated greater improvement on the MADRS.


Nimesh Jhaveri, MBA, RPh

Latest:

Opinion: Patient-Centered Care and the Heart of Independents

"Community pharmacies have reasons to be optimistic..." writes Jhaveri. 



Simon Murray, MD

Latest:

Independent Pharmacy: A Day in the Life

Simon Murray, MD, recently spent the day with Chris Castagna, RPh, an independent pharmacist.


Gabe Weissman

Latest:

Opinion: The Truth About ARCOS and the Opioid Epidemic

The DEA had access to information about where opioids were being sold, but didn’t act on it. Why?


Kevin Luong, PharmD Candidate 2021

Latest:

New Drug Review: Tafamidis Meglumine for Cardiomyopathy

Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.


Leila Khurshid, PharmD, BCPS

Latest:

New Drug Review: Tafamidis Meglumine for Cardiomyopathy

Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.


Silas Inman

Latest:

Toxicity Management Crucial When Combining Novel Agents

Off-label drug combinations are increasingly being used in cancer treatments, but there is the potential for overlapping or additive toxicities, explained a speaker at the 2023 HOPA Annual Conference.


Mike Hennessy Sr

Latest:

Pharmacists Can Help Patients as Signs of Normalcy Return

Although COVID-19 remains a real threat, it seems we are now progressing toward a return to normalcy thanks to the widespread availability of vaccines and tireless efforts of our health care workers.


Jennifer Barrett

Latest:

Build a Successful Hospital Pharmacy Analytics Program

Leverage internal partnerships and demonstrate the value of data


Rania V. Sedhom

Latest:

Can Pharmacists be Blamed as Co-Conspirators in the Opioid Crisis?

What the law says about pharmacists’ role in the opioid crisis-and how to protect yourself.

© 2024 MJH Life Sciences

All rights reserved.